Giovanna Motta

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 11

Top Topics

Diffuse Large B Cell Lymphoma

Epstein Barr Virus

Top Venues

Antibodies (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Alba Guglielmo, Corrado Zengarini, Claudio Agostinelli, Giovanna Motta, Sabattini Elena, Alessandro Pileri
The Role of Cytokines in Cutaneous T Cell Lymphoma: A Focus on the State of the Art and Possible Therapeutic Targets. Cells 13 (7) (2024)
Alba Guglielmo, Corrado Zengarini, Claudio Agostinelli, Giovanna Motta, Sabattini Elena, Alessandro Pileri
The Role of Cytokines in Cutaneous T Cell Lymphoma: A Focus on the State of the Art and Possible Therapeutic Targets. Cells 13 (7) (2024)
Alba Guglielmo, Corrado Zengarini, Claudio Agostinelli, Giovanna Motta, Sabattini Elena, Alessandro Pileri
The Role of Cytokines in Cutaneous T Cell Lymphoma: A Focus on the State of the Art and Possible Therapeutic Targets. Cells 13 (7) (2024)
Corrado Zengarini, Alba Guglielmo, Martina Mussi, Giovanna Motta, Claudio Agostinelli, Sabattini Elena, Bianca Maria Piraccini, Alessandro Pileri
A Narrative Review of the State of the Art of CCR4-Based Therapies in Cutaneous T-Cell Lymphomas: Focus on Mogamulizumab and Future Treatments. Antibodies (Basel, Switzerland) 13 (2) (2024)
Corrado Zengarini, Alba Guglielmo, Martina Mussi, Giovanna Motta, Claudio Agostinelli, Sabattini Elena, Bianca Maria Piraccini, Alessandro Pileri
A Narrative Review of the State of the Art of CCR4-Based Therapies in Cutaneous T-Cell Lymphomas: Focus on Mogamulizumab and Future Treatments. Antibodies (Basel, Switzerland) 13 (2) (2024)
Alba Guglielmo, Corrado Zengarini, Claudio Agostinelli, Giovanna Motta, Sabattini Elena, Alessandro Pileri
The Role of Cytokines in Cutaneous T Cell Lymphoma: A Focus on the State of the Art and Possible Therapeutic Targets. Cells 13 (7) (2024)
Alba Guglielmo, Corrado Zengarini, Claudio Agostinelli, Giovanna Motta, Sabattini Elena, Alessandro Pileri
The Role of Cytokines in Cutaneous T Cell Lymphoma: A Focus on the State of the Art and Possible Therapeutic Targets. Cells 13 (7) (2024)
Saveria Mazzara, Laura Travaini, Francesca Botta, Chiara Granata, Giovanna Motta, Federica Melle, Stefano Fiori, Valentina Tabanelli, Anna Vanazzi, Safaa Ramadan, Tommaso Radice, Sara Raimondi, Giuliana Lo Presti, Mahila Esmeralda Ferrari, Barbara Alicja Jereczek-Fossa, Corrado Tarella, Francesco Ceci, Stefano A Pileri, Enrico Derenzini
Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL. Blood advances 7 (4) (2023)
Saveria Mazzara, Laura Travaini, Francesca Botta, Chiara Granata, Giovanna Motta, Federica Melle, Stefano Fiori, Valentina Tabanelli, Anna Vanazzi, Safaa Ramadan, Tommaso Radice, Sara Raimondi, Giuliana Lo Presti, Mahila Esmeralda Ferrari, Barbara Alicja Jereczek-Fossa, Corrado Tarella, Francesco Ceci, Stefano A Pileri, Enrico Derenzini
Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL. Blood advances 7 (4) (2023)
Saveria Mazzara, Laura Travaini, Francesca Botta, Chiara Granata, Giovanna Motta, Federica Melle, Stefano Fiori, Valentina Tabanelli, Anna Vanazzi, Safaa Ramadan, Tommaso Radice, Sara Raimondi, Giuliana Lo Presti, Mahila Esmeralda Ferrari, Barbara Alicja Jereczek-Fossa, Corrado Tarella, Francesco Ceci, Stefano A Pileri, Enrico Derenzini
Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL. Blood advances 7 (4) (2023)
Valentina Tabanelli, Federica Melle, Giovanna Motta, Saveria Mazzara, Marco Fabbri, Claudio Agostinelli, Angelica Calleri, Marcello Del Corvo, Stefano Fiori, Daniele Lorenzini, Alessandra Cesano, Annalisa Chiappella, Umberto Vitolo, Enrico Derenzini, Gabriel K Griffin, Scott J Rodig, Anna Vanazzi, Elena Sabattini, Corrado Tarella, Maria Rosaria Sapienza, Stefano A Pileri
The identification of TCF1+ progenitor exhausted T cells in THRLBCL may predict a better response to PD-1/PD-L1 blockade. Blood advances 6 (15) (2022)